Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Rezolute announces initiation of Phase 2 study of RZ402 » 07:07
12/15/22
12/15
07:07
12/15/22
07:07
RZLT

Rezolute

$1.52 /

-0.02 (-1.30%)

Rezolute announced that…

Rezolute announced that the Company has initiated a Phase 2 proof-of-concept study for RZ402, a plasma kallikrein inhibitor, PKI, being developed as an oral therapy for the treatment of Diabetic Macular Edema, DME. "We believe that RZ402 represents the potential for a significant change in the treatment paradigm of DME," said Brian Roberts, M.D., Chief Medical Officer at Rezolute. "By targeting this microvascular diabetes complication with an oral-systemic PKI, analogous to the management of other diabetes complications, RZ402 has the potential to improve overall clinical outcomes by driving earlier treatment intervention and preventing disease progression and vision loss for patients with DME. We look forward to building upon the positive data generated in our Phase 1b trial and remain excited by the broad clinical potential of RZ402 to more effectively treat diseases associated with excessive kallikrein-kinin activity."

ShowHide Related Items >><<
RZLT Rezolute
$1.52 /

-0.02 (-1.30%)

09/12/22 Jefferies
Rezolute initiated with a Buy at Jefferies
08/02/22 Canaccord
Rezolute assumed with a Buy at Canaccord
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
RZLT Rezolute
$1.52 /

-0.02 (-1.30%)

RZLT Rezolute
$1.52 /

-0.02 (-1.30%)

Earnings
Rezolute reports Q1 EPS (19c) vs. (92c) last year » 16:20
11/09/22
11/09
16:20
11/09/22
16:20
RZLT

Rezolute

$1.65 /

-0.05 (-2.94%)

ReportsCash and cash…

ReportsCash and cash equivalents totaled $154.3 million as of September 30, 2022.

ShowHide Related Items >><<
RZLT Rezolute
$1.65 /

-0.05 (-2.94%)

RZLT Rezolute
$1.65 /

-0.05 (-2.94%)

09/12/22 Jefferies
Rezolute initiated with a Buy at Jefferies
08/02/22 Canaccord
Rezolute assumed with a Buy at Canaccord
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
RZLT Rezolute
$1.65 /

-0.05 (-2.94%)

RZLT Rezolute
$1.65 /

-0.05 (-2.94%)

Over a quarter ago
Syndicate
Rezolute files to sell 3.24M shares of common stock for holders  16:07
10/28/22
10/28
16:07
10/28/22
16:07
RZLT

Rezolute

$1.69 /

-0.245 (-12.69%)

 
ShowHide Related Items >><<
RZLT Rezolute
$1.69 /

-0.245 (-12.69%)

RZLT Rezolute
$1.69 /

-0.245 (-12.69%)

09/12/22 Jefferies
Rezolute initiated with a Buy at Jefferies
08/02/22 Canaccord
Rezolute assumed with a Buy at Canaccord
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
RZLT Rezolute
$1.69 /

-0.245 (-12.69%)

RZLT Rezolute
$1.69 /

-0.245 (-12.69%)

On The Fly
What You Missed On Wall Street This Morning » 12:02
09/16/22
09/16
12:02
09/16/22
12:02
REGN

Regeneron

$705.37 /

-0.6 (-0.08%)

, FDX

FedEx

$157.46 /

-47.54 (-23.19%)

, TXN

Texas Instruments

$162.79 /

-0.1 (-0.06%)

, NCR

NCR Corp.

$22.34 /

-6.76 (-23.23%)

, HUN

Huntsman

$25.38 /

-1.13 (-4.26%)

, EXR

Extra Space Storage

$182.95 /

-3.79 (-2.03%)

, GS

Goldman Sachs

$323.00 /

-8.73 (-2.63%)

, GOOG

Alphabet

$102.69 /

-1.23 (-1.18%)

, GOOGL

Alphabet

$101.74 /

-1.17 (-1.14%)

, GSK

GSK

$30.66 /

-0.37 (-1.19%)

, TSLA

Tesla

$297.51 /

-6.08 (-2.00%)

, META

Meta Platforms

$145.44 /

-4.14 (-2.77%)

, FE

FirstEnergy

$41.13 /

+0.72 (+1.78%)

, SCHW

Charles Schwab

$71.72 /

-0.9 (-1.24%)

, TNL

Travel + Leisure

$40.57 /

-1.44 (-3.43%)

, BOWL

Bowlero

$13.20 /

+0.69 (+5.52%)

, RZLT

Rezolute

$2.70 /

+ (+0.00%)

, PFE

Pfizer

$45.77 /

-0.16 (-0.35%)

, GOGO

Gogo

$12.74 /

+0.515 (+4.21%)

, BLK

BlackRock

$620.42 /

-11.64 (-1.84%)

, MRK

Merck

$86.95 /

+0.21 (+0.24%)

, ADTX

Aditxt

$4.72 /

-5.67 (-54.57%)

, ALHC

Alignment Healthcare

$13.01 /

-3.03 (-18.89%)

, AA

Alcoa

$42.19 /

-0.95 (-2.20%)

, IP

International Paper

$35.22 /

-4.46 (-11.24%)

, PKG

Packaging Corp.

$116.98 /

-15.84 (-11.93%)

, ADBE

Adobe

$293.92 /

-14.95 (-4.84%)

, SHLS

Shoals Technologies

$24.92 /

+0.15 (+0.61%)

Get caught up quickly on…

ShowHide Related Items >><<
TXN Texas Instruments
$162.79 /

-0.1 (-0.06%)

TSLA Tesla
$297.51 /

-6.08 (-2.00%)

TNL Travel + Leisure
$40.57 /

-1.44 (-3.43%)

SHLS Shoals Technologies
$24.92 /

+0.15 (+0.61%)

SCHW Charles Schwab
$71.72 /

-0.9 (-1.24%)

RZLT Rezolute
$2.70 /

+ (+0.00%)

REGN Regeneron
$705.37 /

-0.6 (-0.08%)

PKG Packaging Corp.
$116.98 /

-15.84 (-11.93%)

PFE Pfizer
$45.77 /

-0.16 (-0.35%)

NCR NCR Corp.
$22.34 /

-6.76 (-23.23%)

MRK Merck
$86.95 /

+0.21 (+0.24%)

META Meta Platforms
$145.44 /

-4.14 (-2.77%)

IP International Paper
$35.22 /

-4.46 (-11.24%)

HUN Huntsman
$25.38 /

-1.13 (-4.26%)

GSK GSK
$30.66 /

-0.37 (-1.19%)

GS Goldman Sachs
$323.00 /

-8.73 (-2.63%)

GOOG Alphabet
$102.69 /

-1.23 (-1.18%)

GOGO Gogo
$12.74 /

+0.515 (+4.21%)

FE FirstEnergy
$41.13 /

+0.72 (+1.78%)

FDX FedEx
$157.46 /

-47.54 (-23.19%)

EXR Extra Space Storage
$182.95 /

-3.79 (-2.03%)

BOWL Bowlero
$13.20 /

+0.69 (+5.52%)

BLK BlackRock
$620.42 /

-11.64 (-1.84%)

ALHC Alignment Healthcare
$13.01 /

-3.03 (-18.89%)

ADTX Aditxt
$4.72 /

-5.67 (-54.57%)

ADBE Adobe
$293.92 /

-14.95 (-4.84%)

AA Alcoa
$42.19 /

-0.95 (-2.20%)

REGN Regeneron
$705.37 /

-0.6 (-0.08%)

09/16/22 Canaccord
Regeneron price target raised to $750 from $700 at Canaccord
09/13/22 Piper Sandler
Regeneron price target raised to $775 from $692 at Piper Sandler
09/12/22 Piper Sandler
Regeneron data at ESMO showcases 'power' of oncology pipeline, says Piper
09/12/22 Guggenheim
Regeneron price target raised to $925 from $740 at Guggenheim
FDX FedEx
$157.46 /

-47.54 (-23.19%)

09/16/22 UBS
FedEx price target lowered to $232 from $308 at UBS
09/16/22 Evercore ISI
FedEx price target lowered to $243 from $318 at Evercore ISI
09/16/22 Wells Fargo
FedEx price target lowered to $199 from $269 at Wells Fargo
09/16/22 Cowen
FedEx price target lowered to $230 from $310 at Cowen
TXN Texas Instruments
$162.79 /

-0.1 (-0.06%)

07/27/22 Baird
CHIPS Act could have deflationary impact on semiconductors, says Baird
07/27/22 Deutsche Bank
Texas Instruments price target raised to $165 from $160 at Deutsche Bank
07/27/22 Mizuho
Texas Instruments price target lowered to $168 from $175 at Mizuho
07/27/22 Citi
Texas Instruments price target raised to $165 from $160 at Citi
NCR NCR Corp.
$22.34 /

-6.76 (-23.23%)

04/27/22 RBC Capital
NCR Corp. price target lowered to $44 from $54 at RBC Capital
04/27/22 Morgan Stanley
NCR Corp. price target lowered to $40 from $61 at Morgan Stanley
01/03/22 Stephens
Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas
11/18/21 Stephens
NCR Corp. initiated with an Overweight at Stephens
HUN Huntsman
$25.38 /

-1.13 (-4.26%)

09/12/22 Credit Suisse
Huntsman initiated with an Outperform at Credit Suisse
08/11/22 RBC Capital
Huntsman price target raised to $43 from $39 at RBC Capital
08/04/22 Citi
Huntsman price target lowered to $34 from $35 at Citi
08/03/22 Deutsche Bank
Huntsman price target lowered to $35 from $40 at Deutsche Bank
EXR Extra Space Storage
$182.95 /

-3.79 (-2.03%)

08/15/22 Truist
Extra Space Storage price target raised to $225 from $200 at Truist
06/30/22 Jefferies
Extra Space Storage price target lowered to $184 from $228 at Jefferies
06/22/22 JPMorgan
Extra Space Storage upgraded to Overweight from Neutral at JPMorgan
06/01/22 Truist
Extra Space Storage price target lowered to $200 from $225 at Truist
GS Goldman Sachs
$323.00 /

-8.73 (-2.63%)

09/12/22 Deutsche Bank
Goldman Sachs price target lowered to $370 from $430 at Deutsche Bank
09/06/22 Odeon Capital
Goldman Sachs downgraded to Sell from Hold at Odeon Capital
07/19/22 BMO Capital
Goldman Sachs price target lowered to $461 from $475 at BMO Capital
07/19/22 Barclays
Goldman Sachs price target lowered to $450 from $505 at Barclays
GOOG Alphabet
$102.69 /

-1.23 (-1.18%)

08/22/22 Evercore ISI
Evercore says Apple getting NFL Sunday Ticket rights makes sense
08/10/22 Oppenheimer
Trade Desk price target raised to $78 from $60 at Oppenheimer
08/09/22 Stifel
Unity price target raised to $60 at Stifel after AppLovin proposal
08/03/22 Tigress Financial
Alphabet price target raised to $186 from $183 at Tigress Financial
GOOGL Alphabet
$101.74 /

-1.17 (-1.14%)

08/10/22 BofA
Meta Platforms added to US 1 List; Alphabet removed at BofA
08/10/22 Needham
Trade Desk price target raised to $65 from $55 at Needham
GSK GSK
$30.66 /

-0.37 (-1.19%)

09/15/22 Credit Suisse
GSK upgraded to Neutral from Underperform at Credit Suisse
09/13/22 Truist
AnaptysBio cut to Hold at Truist with price target of $28
09/08/22 Jefferies
GSK downgraded to Hold from Buy at Jefferies
09/07/22 Deutsche Bank
GSK plc price target lowered to 1,500 GBp from 1,750 GBp at Deutsche Bank
TSLA Tesla
$297.51 /

-6.08 (-2.00%)

09/16/22 Deutsche Bank
Tesla price target raised to $400 from $375 at Deutsche Bank
09/15/22 Wedbush
Biden focused EV initiatives step in right direction, says Wedbush
09/14/22 Needham
Tesla assumed at Hold as Needham doesn't see catalyst for underperformance
09/14/22 Needham
Tesla assumed at Hold from Underperform at Needham
META Meta Platforms
$145.44 /

-4.14 (-2.77%)

09/13/22 Morgan Stanley
Total U.S. time spent on Meta down 3% year/year in August, says Morgan Stanley
09/12/22 Piper Sandler
Meta Platforms price target lowered to $175 from $190 at Piper Sandler
08/22/22 Loop Capital
Meta Platforms price target lowered to $165 from $180 at Loop Capital
08/22/22 Loop Capital
Enovix price target raised to $100 from $50 at Loop Capital
FE FirstEnergy
$41.13 /

+0.72 (+1.78%)

09/16/22 Morgan Stanley
FirstEnergy overhangs getting resolved, says Morgan Stanley
07/18/22 Barclays
FirstEnergy price target lowered to $41 from $49 at Barclays
06/07/22 Mizuho
FirstEnergy estimates lowered on higher costs at Mizuho
05/16/22 BofA
FirstEnergy downgraded to Neutral from Buy at BofA
SCHW Charles Schwab
$71.72 /

-0.9 (-1.24%)

09/16/22 UBS
Charles Schwab price target raised to $85 from $82 at UBS
08/31/22 Barclays
Charles Schwab initiated with an Equal Weight at Barclays
08/19/22 Deutsche Bank
Charles Schwab price target raised to $95 from $90 at Deutsche Bank
08/12/22 Deutsche Bank
Charles Schwab price target raised to $90 from $83 at Deutsche Bank
TNL Travel + Leisure
$40.57 /

-1.44 (-3.43%)

08/12/22 Truist
Travel + Leisure price target lowered to $72 from $78 at Truist
08/01/22 Deutsche Bank
Travel + Leisure price target lowered to $69 from $76 at Deutsche Bank
07/28/22 Stifel
Travel + Leisure price target lowered to $61 from $76 at Stifel
06/28/22 Barclays
Travel + Leisure initiated with an Equal Weight at Barclays
BOWL Bowlero
$13.20 /

+0.69 (+5.52%)

09/16/22 JPMorgan
Bowlero price target raised to $18 from $17 at JPMorgan
09/16/22 MKM Partners
Bowlero price target raised to $17 from $14 at MKM Partners
08/30/22 JPMorgan
JPMorgan starts Bowlero at Overweight on 'economically-attractive' industry
08/30/22 JPMorgan
Bowlero initiated with an Overweight at JPMorgan
RZLT Rezolute
$2.70 /

+ (+0.00%)

09/12/22 Jefferies
Rezolute initiated with a Buy at Jefferies
08/02/22 Canaccord
Rezolute assumed with a Buy at Canaccord
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
PFE Pfizer
$45.77 /

-0.16 (-0.35%)

09/13/22 Truist
Concert Pharmaceuticals price target raised to $25 from $22 at Truist
09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
08/18/22 Piper Sandler
Biohaven downgraded to Neutral from Overweight at Piper Sandler
GOGO Gogo
$12.74 /

+0.515 (+4.21%)

09/08/22 William Blair
William Blair says buy Iridium on selloff from Apple, Globalstar pact
05/24/22 William Blair
Gogo pact with Echostar doubles addressable market, says William Blair
04/26/22 Northland
SpaceX's Starlink deal with Hawaiian highlights risk for Gogo, says Northland
03/24/22 William Blair
Gogo shares headed to low $30s by 2024, says William Blair
BLK BlackRock
$620.42 /

-11.64 (-1.84%)

08/12/22 Deutsche Bank
BlackRock price target raised to $860 from $720 at Deutsche Bank
08/04/22 JMP Securities
JMP 'encouraged' by Coinbase partnership with BlackRock's Aladdin
07/18/22 Deutsche Bank
BlackRock price target lowered to $720 from $725 at Deutsche Bank
07/13/22 Deutsche Bank
BlackRock price target lowered to $725 from $747 at Deutsche Bank
MRK Merck
$86.95 /

+0.21 (+0.24%)

09/14/22 Berenberg
Merck upgraded to Buy from Hold at Berenberg
08/25/22 Erste Group
Merck upgraded to Buy from Hold at Erste Group
08/18/22 Wells Fargo
Sutro Biopharma assumed with an Overweight at Wells Fargo
08/17/22 Barclays
Gossamer Bio price target raised to $18 from $12 at Barclays
ADTX Aditxt
$4.72 /

-5.67 (-54.57%)

09/16/22 Dawson James
Aditx Therapeutics downgraded to Neutral from Buy at Dawson James
12/23/21
Aditx Therapeutics price target raised to $6 from $4 at Dawson James
ALHC Alignment Healthcare
$13.01 /

-3.03 (-18.89%)

09/08/22 Piper Sandler
Alignment Healthcare assumed with an Overweight at Piper Sandler
08/22/22 Cowen
Alignment Healthcare price target raised to $17 from $12 at Cowen
08/08/22 UBS
Alignment Healthcare price target raised to $17 from $11 at UBS
08/08/22 Barclays
Alignment Healthcare price target raised to $21 from $14 at Barclays
AA Alcoa
$42.19 /

-0.95 (-2.20%)

09/16/22 Morgan Stanley
Alcoa upgraded to Overweight from Equal Weight at Morgan Stanley
07/25/22 Morgan Stanley
Alcoa price target lowered to $51 from $55 at Morgan Stanley
07/21/22 BMO Capital
Alcoa price target lowered to $55 from $57 at BMO Capital
07/19/22 Credit Suisse
Alcoa price target lowered to $63 from $82 at Credit Suisse
IP International Paper
$35.22 /

-4.46 (-11.24%)

09/16/22 Jefferies
International Paper downgraded to Underperform from Hold at Jefferies
08/01/22 Jefferies
Jefferies sees increased risk of International Paper, WestRock prices falling
07/19/22 Deutsche Bank
International Paper price target lowered to $44 from $48 at Deutsche Bank
07/18/22 Wells Fargo
Wells Fargo downgrades International Paper to Equal Weight
PKG Packaging Corp.
$116.98 /

-15.84 (-11.93%)

09/16/22 Jefferies
Packaging Corp. downgraded to Underperform from Hold at Jefferies
07/27/22 Wells Fargo
Packaging Corp. price target lowered to $143 from $154 at Wells Fargo
07/27/22 Citi
Packaging Corp. price target raised to $147 from $144 at Citi
07/19/22 Deutsche Bank
Packaging Corp. price target lowered to $144 from $158 at Deutsche Bank
ADBE Adobe
$293.92 /

-14.95 (-4.84%)

09/16/22 Evercore ISI
Adobe price target lowered to $350 from $475 at Evercore ISI
09/16/22 BMO Capital
Adobe price target lowered to $345 from $435 at BMO Capital
09/16/22 Cowen
Adobe price target lowered to $400 from $520 at Cowen
09/16/22 Credit Suisse
Adobe price target lowered to $350 from $425 at Credit Suisse
SHLS Shoals Technologies
$24.92 /

+0.15 (+0.61%)

09/16/22 Cowen
Cowen upgrades Shoals to Outperform, sees 'compelling opportunity'
09/16/22 Cowen
Shoals Technologies upgraded to Outperform from Market Perform at Cowen
09/09/22 Guggenheim
Shoals downgraded to Neutral on valuation at Guggenheim
09/09/22 Guggenheim
Shoals Technologies downgraded to Neutral from Buy at Guggenheim
TXN Texas Instruments
$162.79 /

-0.1 (-0.06%)

TSLA Tesla
$297.51 /

-6.08 (-2.00%)

TNL Travel + Leisure
$40.57 /

-1.44 (-3.43%)

SHLS Shoals Technologies
$24.92 /

+0.15 (+0.61%)

SCHW Charles Schwab
$71.72 /

-0.9 (-1.24%)

RZLT Rezolute
$2.70 /

+ (+0.00%)

REGN Regeneron
$705.37 /

-0.6 (-0.08%)

PKG Packaging Corp.
$116.98 /

-15.84 (-11.93%)

PFE Pfizer
$45.77 /

-0.16 (-0.35%)

NCR NCR Corp.
$22.34 /

-6.76 (-23.23%)

MRK Merck
$86.95 /

+0.21 (+0.24%)

META Meta Platforms
$145.44 /

-4.14 (-2.77%)

IP International Paper
$35.22 /

-4.46 (-11.24%)

HUN Huntsman
$25.38 /

-1.13 (-4.26%)

GSK GSK
$30.66 /

-0.37 (-1.19%)

GS Goldman Sachs
$323.00 /

-8.73 (-2.63%)

GOOG Alphabet
$102.69 /

-1.23 (-1.18%)

GOGO Gogo
$12.74 /

+0.515 (+4.21%)

FE FirstEnergy
$41.13 /

+0.72 (+1.78%)

FDX FedEx
$157.46 /

-47.54 (-23.19%)

EXR Extra Space Storage
$182.95 /

-3.79 (-2.03%)

BOWL Bowlero
$13.20 /

+0.69 (+5.52%)

BLK BlackRock
$620.42 /

-11.64 (-1.84%)

ALHC Alignment Healthcare
$13.01 /

-3.03 (-18.89%)

ADBE Adobe
$293.92 /

-14.95 (-4.84%)

AA Alcoa
$42.19 /

-0.95 (-2.20%)

  • 16
    Sep
  • 16
    Sep
  • 24
    Aug
  • 02
    Aug
  • 13
    Jan
  • 19
    Nov
  • 13
    Oct
TXN Texas Instruments
$162.79 /

-0.1 (-0.06%)

TSLA Tesla
$297.51 /

-6.08 (-2.00%)

SHLS Shoals Technologies
$24.92 /

+0.15 (+0.61%)

SCHW Charles Schwab
$71.72 /

-0.9 (-1.24%)

REGN Regeneron
$705.37 /

-0.6 (-0.08%)

PFE Pfizer
$45.77 /

-0.16 (-0.35%)

NCR NCR Corp.
$22.34 /

-6.76 (-23.23%)

MRK Merck
$86.95 /

+0.21 (+0.24%)

META Meta Platforms
$145.44 /

-4.14 (-2.77%)

HUN Huntsman
$25.38 /

-1.13 (-4.26%)

GSK GSK
$30.66 /

-0.37 (-1.19%)

GS Goldman Sachs
$323.00 /

-8.73 (-2.63%)

GOOG Alphabet
$102.69 /

-1.23 (-1.18%)

FDX FedEx
$157.46 /

-47.54 (-23.19%)

BLK BlackRock
$620.42 /

-11.64 (-1.84%)

ADBE Adobe
$293.92 /

-14.95 (-4.84%)

AA Alcoa
$42.19 /

-0.95 (-2.20%)

TXN Texas Instruments
$162.79 /

-0.1 (-0.06%)

TSLA Tesla
$297.51 /

-6.08 (-2.00%)

SHLS Shoals Technologies
$24.92 /

+0.15 (+0.61%)

SCHW Charles Schwab
$71.72 /

-0.9 (-1.24%)

REGN Regeneron
$705.37 /

-0.6 (-0.08%)

PFE Pfizer
$45.77 /

-0.16 (-0.35%)

NCR NCR Corp.
$22.34 /

-6.76 (-23.23%)

MRK Merck
$86.95 /

+0.21 (+0.24%)

META Meta Platforms
$145.44 /

-4.14 (-2.77%)

IP International Paper
$35.22 /

-4.46 (-11.24%)

HUN Huntsman
$25.38 /

-1.13 (-4.26%)

GSK GSK
$30.66 /

-0.37 (-1.19%)

GS Goldman Sachs
$323.00 /

-8.73 (-2.63%)

GOOG Alphabet
$102.69 /

-1.23 (-1.18%)

GOGO Gogo
$12.74 /

+0.515 (+4.21%)

FDX FedEx
$157.46 /

-47.54 (-23.19%)

EXR Extra Space Storage
$182.95 /

-3.79 (-2.03%)

BOWL Bowlero
$13.20 /

+0.69 (+5.52%)

BLK BlackRock
$620.42 /

-11.64 (-1.84%)

ADBE Adobe
$293.92 /

-14.95 (-4.84%)

AA Alcoa
$42.19 /

-0.95 (-2.20%)

TXN Texas Instruments
$162.79 /

-0.1 (-0.06%)

TSLA Tesla
$297.51 /

-6.08 (-2.00%)

SHLS Shoals Technologies
$24.92 /

+0.15 (+0.61%)

SCHW Charles Schwab
$71.72 /

-0.9 (-1.24%)

REGN Regeneron
$705.37 /

-0.6 (-0.08%)

PFE Pfizer
$45.77 /

-0.16 (-0.35%)

NCR NCR Corp.
$22.34 /

-6.76 (-23.23%)

MRK Merck
$86.95 /

+0.21 (+0.24%)

META Meta Platforms
$145.44 /

-4.14 (-2.77%)

GSK GSK
$30.66 /

-0.37 (-1.19%)

GS Goldman Sachs
$323.00 /

-8.73 (-2.63%)

GOOGL Alphabet
$101.74 /

-1.17 (-1.14%)

GOOG Alphabet
$102.69 /

-1.23 (-1.18%)

FE FirstEnergy
$41.13 /

+0.72 (+1.78%)

FDX FedEx
$157.46 /

-47.54 (-23.19%)

EXR Extra Space Storage
$182.95 /

-3.79 (-2.03%)

BOWL Bowlero
$13.20 /

+0.69 (+5.52%)

ADBE Adobe
$293.92 /

-14.95 (-4.84%)

AA Alcoa
$42.19 /

-0.95 (-2.20%)

Earnings
Rezolute reports Q4 EPS (37c), consensus (41c) » 16:07
09/15/22
09/15
16:07
09/15/22
16:07
RZLT

Rezolute

$2.71 /

-0.01 (-0.37%)

Cash and cash equivalents…

Cash and cash equivalents totaled $150.4M as of June 30. "This quarter marked steady progress as we continue to drive our clinical programs forward, including RZ358 for congenital hyperinsulinism and RZ402 for diabetic macular edema," said Nevan Charles Elam, CEO and Founder of Rezolute. "With the $130 million financing that we completed, we are well-capitalized to advance RZ358 into a Phase 3 trial and to initiate a Phase 2 proof-of-concept study for RZ402. We believe these candidates hold the potential to create a new standard of care for patient populations in need of better therapeutic options."

ShowHide Related Items >><<
RZLT Rezolute
$2.71 /

-0.01 (-0.37%)

RZLT Rezolute
$2.71 /

-0.01 (-0.37%)

09/12/22 Jefferies
Rezolute initiated with a Buy at Jefferies
08/02/22 Canaccord
Rezolute assumed with a Buy at Canaccord
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
RZLT Rezolute
$2.71 /

-0.01 (-0.37%)

  • 13
    Oct
Initiation
Rezolute initiated with a Buy at Jefferies » 08:11
09/12/22
09/12
08:11
09/12/22
08:11
RZLT

Rezolute

$2.27 /

+0.12 (+5.58%)

Jefferies analyst Maury…

Jefferies analyst Maury Raycroft initiated coverage of Rezolute with a Buy rating and $11 price target. Lead asset RZ358 is a "differentiated" monoclonal antibody being developed for the ultra-rare indication Congenital Hyperinsulinism, or CHI, said Raycroft, who views the antibody as "derisked by promising" phase IIb data. The company's second clinical-stage asset, RZ402, is an oral plasma kallikrein inhibitor for Diabetic Macular Edema, or DME, which he views having "a riskier, but high reward path," the analyst added.

ShowHide Related Items >><<
RZLT Rezolute
$2.27 /

+0.12 (+5.58%)

RZLT Rezolute
$2.27 /

+0.12 (+5.58%)

08/02/22 Canaccord
Rezolute assumed with a Buy at Canaccord
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
03/23/22 JMP Securities
Rezolute Phase 2 results bode well for approval, says JMP Securities
RZLT Rezolute
$2.27 /

+0.12 (+5.58%)

  • 13
    Oct
Initiation
Rezolute assumed with a Buy at Canaccord » 06:22
08/02/22
08/02
06:22
08/02/22
06:22
RZLT

Rezolute

$3.09 /

+0.005 (+0.16%)

Canaccord analyst Edward…

Canaccord analyst Edward Nash assumed coverage of Rezolute with a Buy rating and $17 price target. The developmental-stage biopharmaceutical company's two pipeline programs, RZ358 for congenital hyperinsulinism and RZ402 for diabetic macular edema, use differentiated mechanisms of action compared to existing treatments, said Nash, who sees an upside opportunity for RZ358 in post-gastric bypass surgery and a "substantial market opportunity" for RZ402 in DME.

ShowHide Related Items >><<
RZLT Rezolute
$3.09 /

+0.005 (+0.16%)

RZLT Rezolute
$3.09 /

+0.005 (+0.16%)

06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
03/23/22 JMP Securities
Rezolute Phase 2 results bode well for approval, says JMP Securities
03/23/22 Roth Capital
Rezolute price target raised to $25 from $23 at Roth Capital
RZLT Rezolute
$3.09 /

+0.005 (+0.16%)

  • 13
    Oct
Syndicate
Rezolute files to sell 10.95M shares of common stock for holders  17:04
06/17/22
06/17
17:04
06/17/22
17:04
RZLT

Rezolute

$3.18 /

+0.015 (+0.47%)

 
ShowHide Related Items >><<
RZLT Rezolute
$3.18 /

+0.015 (+0.47%)

RZLT Rezolute
$3.18 /

+0.015 (+0.47%)

06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
03/23/22 JMP Securities
Rezolute Phase 2 results bode well for approval, says JMP Securities
03/23/22 Roth Capital
Rezolute price target raised to $25 from $23 at Roth Capital
RZLT Rezolute
$3.18 /

+0.015 (+0.47%)

  • 13
    Oct
Initiation
Rezolute initiated with an Overweight at Cantor Fitzgerald » 07:34
06/15/22
06/15
07:34
06/15/22
07:34
RZLT

Rezolute

$3.03 /

+0.025 (+0.83%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pete Stavropoulos initiated coverage of Rezolute with an Overweight rating and $9 price target. An approval of lead candidate RZ358 could make it a cornerstone of the congenital hyperinsulinism treatment paradigm that commands rare disease drug pricing observed for highly efficacious agents, potentially leading to a greater than $500M revenue generator by 2030, if the compelling data observed in the Phase 2b RIZE study is replicated in a registrational study, Stavropoulos tells investors in a research note.

ShowHide Related Items >><<
RZLT Rezolute
$3.03 /

+0.025 (+0.83%)

RZLT Rezolute
$3.03 /

+0.025 (+0.83%)

06/15/22 Cantor Fitzgerald
Rezolute initiated with an Overweight at Cantor Fitzgerald
03/23/22 JMP Securities
Rezolute Phase 2 results bode well for approval, says JMP Securities
03/23/22 Roth Capital
Rezolute price target raised to $25 from $23 at Roth Capital
02/23/22 Roth Capital
Roth Capital raises Rezolute price target to $23 following MAD PK data for RZ402
RZLT Rezolute
$3.03 /

+0.025 (+0.83%)

  • 13
    Oct
Initiation
Rezolute initiated with an Overweight at Cantor Fitzgerald » 06:26
06/15/22
06/15
06:26
06/15/22
06:26
RZLT

Rezolute

$3.03 /

+0.025 (+0.83%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pete Stavropoulos initiated coverage of Rezolute with an Overweight rating and $9 price target.

ShowHide Related Items >><<
RZLT Rezolute
$3.03 /

+0.025 (+0.83%)

RZLT Rezolute
$3.03 /

+0.025 (+0.83%)

03/23/22 JMP Securities
Rezolute Phase 2 results bode well for approval, says JMP Securities
03/23/22 Roth Capital
Rezolute price target raised to $25 from $23 at Roth Capital
02/23/22 Roth Capital
Roth Capital raises Rezolute price target to $23 following MAD PK data for RZ402
01/12/22 Roth Capital
Rezolute data readout catalysts on track for Q1, says Roth Capital
RZLT Rezolute
$3.03 /

+0.025 (+0.83%)

  • 13
    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.